Inactive Instrument

Affinity Energy and Health Limited

Equities

AEB

AU000000AEB3

Algae Tec : Dispatch of Rights Issue Prospectus Completed

July 13, 2017 at 09:29 pm EDT

12 July 2017

ASX Announcement

The Manager Announcements Company Announcements Office ASX Limited

20 Bridge Street

SYDNEY NSW 2000

Dispatch of Rights Issue Prospectus Completed

Algae.Tec Limited (ASX: "AEB") confirms that the Rights Issue Prospectus, the Entitlement and Acceptance Form were dispatched to Shareholders on 12 July 2017.

Should you have any queries please contact the Company Secretary on 08 9380 6790. Peter Hatfull

Company Secretary

Algae.Tec Limited published this content on 12 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 July 2017 01:29:08 UTC.

Original documenthttp://algaetec.com.au/index.php/investors/asx-announcements?task=document.viewdoc&id=96

Public permalinkhttp://www.publicnow.com/view/764731FF0A65E7297F84EF2B0D248BD363E45352

Latest news about Affinity Energy and Health Limited

Affinity Energy and Health Limited Announces Director Changes	20-12-15	CI
Affinity Energy and Health Limited Announces Resignation of Gregory Barry Starr from the Board as a Non-Executive Director	20-11-16	CI
Affinity Energy & Health Limited Announces Management Changes	20-11-13	CI
Affinity Energy and Health Limited Announces Director Appointments	20-10-26	CI
Alterola Biotech, Inc. cancelled the acquisition of Algae Energy, Inc. from Affinity Energy and Health Limited.	20-05-26	CI
Affinity Energy and Health Limited Announces Executive Changes	20-01-06	CI
Affinity Energy and Health Limited Announces Management Changes	19-10-25	CI
Affinity Energy and Health Limited Announces Board Changes	19-09-18	CI
Affinity Energy and Health Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-09-01	CI
Alterola Biotech, Inc. entered into an agreement to acquire Algae Energy, Inc. from Affinity Energy and Health Limited for $0.6 million.	19-08-25	CI
Affinity Energy and Health Limited Announces Management Changes	19-06-14	CI
Affinity Energy and Health Limited Announces Board Appointment and Resignations	19-04-08	CI
Affinity Energy and Health Limited Reports Earnings Results for the Half Year Ended December 31, 2018	19-02-28	CI
Algae.Tec Limited cancelled the acquisition of 19.9% stake in NS Technologies Pty Ltd.	19-02-11	CI
Affinity Energy & Health Ltd Announces Resignation of Allan Tan as Director	19-01-13	CI
Affinity Energy and Health and St John of God Health Care Inc. Sign Heads of Agreement to Research Medical Cannabis	18-12-05	CI
Affinity Energy & Health Limited Approves to Establish a Medicinal Cannabis Cultivation and Manufacturing Facility in the Republic of Malta	18-12-03	CI
Affinity Energy and Health Limited and Skin Elements Limited Enter into Memorandum of Understanding to Develop Skin Care Products	18-10-07	CI
Affinity Energy & Health Announces Distribution Agreement with Seachem Laboratories, Inc	18-10-01	CI
Affinity Energy and Health Limited Announces Audited Parent and Consolidated Earnings Results for the Year Ended June 30, 2018	18-09-28	CI
Affinity Energy and Health Limited Announces Preliminary Consolidated Earnings Results for the Year Ended June 30, 2018	18-08-30	CI
Affinity Energy and Health Limited Enters R&D Partnership with the University of Sydney to Drive Medicinal Cannabis Strategy	18-08-29	CI
Algae.Tec Ltd will Change its Name to Affinity Energy & Health Ltd	18-08-29	CI
Affinity Energy and Health Limited announced that it expects to receive AUD 7 million in funding from Magna Management LLC	18-06-07	CI
Algae.Tec Limited Announces Consolidated Earnings Results for the Half Year Ended December 31, 2017	18-02-28	CI

Chart Affinity Energy and Health Limited

Duration

Period

Chart Affinity Energy and Health Limited

More charts

Company Profile

Affinity Energy and Health Ltd, formerly Algae.Tec Ltd, is an Australia-based plant-based health and wellbeing company. The Company is focused on developing technology to produce commercial quantities of algae and medicinal cannabis. It focuses on four markets: medicinal cannabis, algae-based nutraceuticals, animal feed and aquaculture markets and biofuels. It operates a facility in Atlanta, which produces algae species, which includes Athrospira (Spirulina), Chlorella, Dunaliella, Nannochloropsis, Haematococcus and Schizochytrium, to both the nutraceutical and aqua feed markets. FeedMe is its algae line of products. Spirulina is its natural algal powder and is a source of antioxidants, B-vitamins and other nutrients. The Company utilizes algae to produce biofuels at its Reliance Plant in India.

Sector

More about the company